comparing dasatinib-blinatumomab vs ponatinib-blinatumomab in newly diagnosed ph b-all
Published 5 months ago • 95 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
2:12
investigating the efficacy of ponatinib and blinatumomab for patients with newly diagnosed ph all
-
3:19
blinatumomab plus ponatinib for ph all
-
1:12
ponatinib and blinatumomab in newly diagnosed ph all: subgroup analysis from phase ii study
-
2:32
blinatumomab and ponatinib in newly diagnosed ph all: updates from a phase ii trial
-
1:59
final analysis of the gimema lal2116 (d-alba) trial: dasatinib blinatumomab in ph b-all
-
0:55
phallcon: phase iii study of ponatinib vs imatinib in newly diagnosed ph all
-
1:54
ponatinib and blinatumomab for the treatment of ph all
-
3:03
swog 1318: dasatinib plus blinatumomab in the treatment of older patients with b-all
-
9:16
protrombin time (pt) & activated partial tromboplastin time (aptt)|coagulation analyzer|wila djami
-
9:21
the evolution of treatment of ph all & phase ii study of blinatumomab and ponatinib in ph all
-
2:51
the use of asciminib versus ponatinib for multiresistant cml
-
2:31
ponatinib & blinatumomab for ph all
-
9:02
dasatinib-blinatumomab for adult ph all
-
1:03
updated results of hyper-cvad and blinatumomab /- inotuzumab ozogamicin in newly-diagnosed b-all
-
1:54
final results of the gimema lal2317 trial: sequential chemotherapy blinatumomab for ph- b-all
-
2:48
dasatinib-blinatumomab for all
-
1:24
immunotherapy with blinatumomab vs chemotherapy in pediatric patients with newly diagnosed b-all
-
4:38
blinatumomab vs inotuzumab ozogamicin for all
-
0:22
blinatumomab plus ponatinib for all update coming soon at eha 2021
-
3:04
b-all patient selection for treatment with blinatumomab
-
0:44
the recent fda approval of ponatinib for ph all following success in the phallcon trial
-
2:28
blinatumomab as consolidation for adult b-all